234 related articles for article (PubMed ID: 35873103)
21. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
[TBL] [Abstract][Full Text] [Related]
22. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
Ma H; O'Connor OA; Marchi E
Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
[TBL] [Abstract][Full Text] [Related]
23. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop.
Ondrejka SL; Amador C; Climent F; Ng SB; Soma L; Zamo A; Dirnhofer S; Quintanilla-Martinez L; Wotherspoon A; Leoncini L; de Leval L
Virchows Arch; 2023 Sep; 483(3):349-365. PubMed ID: 37500795
[TBL] [Abstract][Full Text] [Related]
24. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
[TBL] [Abstract][Full Text] [Related]
25. A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma.
Kurita D; Miyoshi H; Yoshida N; Sasaki Y; Kato S; Niino D; Sugita Y; Hatta Y; Takei M; Makishima M; Ohshima K
Am J Surg Pathol; 2016 Sep; 40(9):1249-60. PubMed ID: 27428734
[TBL] [Abstract][Full Text] [Related]
26. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
[TBL] [Abstract][Full Text] [Related]
27. Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.
Manso R; González-Rincón J; Rodríguez-Justo M; Roncador G; Gómez S; Sánchez-Beato M; Piris MA; Rodríguez-Pinilla SM
Oncotarget; 2018 Mar; 9(22):16124-16133. PubMed ID: 29662631
[TBL] [Abstract][Full Text] [Related]
28. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
29. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
Mihashi Y; Kimura S; Iwasaki H; Oshiro Y; Takamatsu Y; Kawauchi S; Shimajiri S; Ishizuka K; Takeshita M
Diagn Pathol; 2021 Nov; 16(1):101. PubMed ID: 34742294
[TBL] [Abstract][Full Text] [Related]
30. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring.
Wang J; Tang W; Zhang W; Wang J; Chen F; Zhong L; Chen Y; Chen G
Virchows Arch; 2021 Aug; 479(2):355-363. PubMed ID: 33650043
[TBL] [Abstract][Full Text] [Related]
32. Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type.
Harland L; Borgmann V; Otto F; Overkamp M; Bonzheim I; Fend F; Quintanilla-Martinez L; Nann D
Mod Pathol; 2024 May; 37(7):100519. PubMed ID: 38777036
[TBL] [Abstract][Full Text] [Related]
33. An Isolated Mesenteric Presentation of a Nodal Peripheral T Cell Lymphoma with T Follicular Helper Cell Phenotype.
Keogh A; Lynott F; Papanicolau-Sengos A; Mohammed Nur M; Spillane A; Quinn F; ElHassadi E; Jaffe ES; Flavin R
Hematol Rep; 2022 Nov; 14(4):335-341. PubMed ID: 36412627
[TBL] [Abstract][Full Text] [Related]
34. RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases.
Miyoshi H; Sakata-Yanagimoto M; Shimono J; Yoshida N; Hattori K; Arakawa F; Yanagida E; Takeuchi M; Yamada K; Suzuki T; Moritsubo M; Furuta T; Chiba S; Ohshima K
Pathol Int; 2020 Sep; 70(9):653-660. PubMed ID: 32648273
[TBL] [Abstract][Full Text] [Related]
35. Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.
Ahearne MJ; Allchin RL; Fox CP; Wagner SD
Br J Haematol; 2014 Aug; 166(3):326-35. PubMed ID: 24815671
[TBL] [Abstract][Full Text] [Related]
36. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
Cetinözman F; Jansen PM; Willemze R
Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
[TBL] [Abstract][Full Text] [Related]
37. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
38. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
[TBL] [Abstract][Full Text] [Related]
39. Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.
Krug A; Tari G; Saidane A; Gaulard P; Ricci JE; Lemonnier F; Verhoeyen E
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625998
[TBL] [Abstract][Full Text] [Related]
40. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
Ghione P; Faruque P; Mehta-Shah N; Seshan V; Ozkaya N; Bhaskar S; Yeung J; Spinner MA; Lunning M; Inghirami G; Moskowitz A; Galasso N; Ganesan N; van der Weyden C; Ruan J; Prince HM; Trotman J; Advani R; Dogan A; Horwitz S
Blood Adv; 2020 Oct; 4(19):4640-4647. PubMed ID: 33002132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]